Subject to shareholder approval at the subsequent Annual General Meeting (AGM), the Board of Directors of Sanofi Consumer ...

The medicine is so popular that most paracetamol products ... the-counter vitamins, minerals, and supplements market. Given Opella’s significant economic contribution to France, Sanofi’s ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in ...

These products are sold principally in the prescription market, but the company also develops over-the-counter medication as well. Sanofi now covers seven major therapeutic areas: Sanofi’s CEO ...

A line extension of one of Sanofi Indias flagship brand Combiflam, the launch of this new product marks the companys foray into the OTC headache segment in India.On 11 November 2014, Sanofi India ...

Czech Republic-based Zentiva Pharma, a generics and over-the-counter medicines company that is wholly-owned by private equity ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

1 Dupilumab is being jointly developed by Regeneron and Sanofi under a global collaboration agreement ... including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version ...

Pharma - STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty ...